Press release
Global Acromegaly Drugs Market , Size, Share, Analysis Report & Forecast to 2026
The Acromegaly Drug Market is expected to register a CAGR of 7.2% during the forecast period. Acromegaly is a hormonal condition that occurs when the pituitary gland produces too much growth hormone in maturity.Bones develop in size, when you have too much growth hormone. This causes gigantism in children, which is defined as an increase in height. In adulthood, however, there is no variation in height. Instead, acromegaly refers to an increase in bone size that is limited to the bones of your hands, foot, and face. Hypertension, osteoarthritis, diabetes mellitus, goitre, and eyesight loss are some of the problems associated with acromegaly progression.
Free Sample Copy @ https://www.omrglobal.com/request-sample/acromegaly-drugs-market
Acromegaly affects around 69,000 people globally and about 24,000 in the US, of whom an estimated 8,000 are treated chronically with somatostatin analogue injections. According to the National Institutes of Health (NIH), there are three to four new cases per million each year.
The rising Global Knowledge about hormonal problem, medication and therapies drives the market during the forecast period.
The improvement in the patient's overall clinical status as a result of the treatment is a significant contributor to the market's growth.
A Full Report of Global Acromegaly Drugs Market is Available at:
https://www.omrglobal.com/industry-reports/acromegaly-drugs-market
An increase in the number of patients with this rare disease, particularly among the adult population, enhances demand for the drug, which is expected to fuel market expansion significantly during the forecast years.
Technological advancements and increased R&D expenditure from major manufacturers, in discovery of innovative goods are giving profitable chances, that will fuel market growth over the forecast years.
In March 2021, the US Food and Drug Administration (FDA) approved MYCAPSSA (octreotide) delayed-release capsules, for oral use, is a somatostatin analog indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.
Global Acromegaly Drugs Market – Segmentation
by Product Type
Somatostatin Analogs
Growth Hormone Receptor Antagonist (GHRA)
Dopamine Agonists
Other Product Types
by application
Hospital
Pharmacy
Global Acromegaly Drugs Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Pfizer Inc
Novartis AG
Validus Pharmaceuticals LLC
Ipsen
Chiasma Inc
Ionis Pharmaceuticals Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/acromegaly-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Acromegaly Drugs Market , Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2418902 • Views: …
More Releases from Orion Market Research
Eyelid Surgery Market Size Future Scope, Demands and Projected Industry Growths …
Eyelid surgery market was valued at approximately USD 6.94 billion, and it is projected to reach USD 11.84 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5.49 % from 2024 to 2033.
Eyelid Surgery Market Overview
The eyelid surgery market, encompassing both functional and aesthetic procedures, is experiencing significant growth driven by an aging global population and increasing demand for cosmetic enhancements. Procedures like blepharoplasty-surgical correction of drooping…
Aviation Programming Software Market Size Analysis, Competitive Insights, Leadin …
Aviation Programming Software Market was valued at approximately USD 1.3 billion, and it is anticipated to grow to about USD 2.4 billion by 2033, reflecting a compound annual growth rate (CAGR) of roughly 7.1% from 2024 to 2033.
Aviation Programming Software Market Overview
The Aviation Programming Software Market encompasses specialized applications designed to optimize areas like flight planning, aircraft maintenance, crew scheduling, air traffic control, and operational integration. Demand is rising…
Artificial Intelligence in Cancer Diagnostics Market : A Guide to Understanding …
Artificial Intelligence in Cancer Diagnostics market was valued at approximately USD 0.2 billion, and it is projected to reach around USD 1.7 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 23.6 % from 2024 to 2033
Artificial Intelligence in Cancer Diagnostics Market Overview
The Artificial Intelligence in Cancer Diagnostics Market is undergoing rapid expansion as AI-driven tools are increasingly integrated into cancer detection and diagnosis workflows. These AI…
Fetal Electronic Cardiodiagram (FECG) Monitors Market Size Future Scope, Demands …
FECG Monitor Market was valued at approximately USD 1.5 billion, and it is expected to grow to around USD 2.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.5 % from 2026 to 2033.
Fetal Electronic Cardiodiagram (FECG) Monitors Market Overview
The Fetal Electronic Cardiotocogram (FECG) Monitors Market is a dynamic niche within maternal health technology, fueling demand for high-precision monitoring of fetal heart activity. FECG monitors-both standalone…
More Releases for Acromegaly
Rising Hormonal Disease Prevalence Powers Growth In The Acromegaly Market: Key F …
The Acromegaly Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Acromegaly Market Size During the Forecast Period?
The market size for acromegaly has experienced swift expansion in the latest years. It is projected to rise from $2.15 billion in 2024 to $2.57…
Acromegaly Global Market Report 2025: Surge in Acromegaly Cases Driving Market G …
Rapid growth is expected in the Acromegaly global market, driven by rising awareness, government initiatives, and demand for effective treatments.
What Is The Projected Market Size Of The Global Acromegaly Global Market Report 2025 And Its Growth Rate?
The acromegaly market size is set for considerable growth in the coming years. Key statistics include:
• The market size grew from $2.15 billion in 2024 to an estimated $2.57 billion in 2025.
• This represents…
Exploring Acromegaly Treatment Market Growth
The global acromegaly treatment market is experiencing robust growth, with no signs of slowing down. In 2023, this market reached a significant milestone, boasting a total value of USD 1.61 billion. The future looks even more promising, with a projected compound annual growth rate (CAGR) of 7.65% from 2024 to 2032. By the end of this period, the market is expected to soar to approximately USD 3.12 billion. But what's…
Acromegaly Market - Defeating Acromegaly, Restoring Lives
Newark, New Castle, USA: The "Acromegaly Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Acromegaly Market: https://www.growthplusreports.com/report/acromegaly-market/8421
This latest report researches the industry structure, sales, revenue, price and…
Acromegaly - Drug Pipeline Landscape, 2022
Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights.
The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes pituitary gland to release excess growth hormone…
Acromegaly - Drug Pipeline Landscape, 2022
Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights.
The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes pituitary gland to release excess growth hormone…
